Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00389441 · ClinicalTrials.gov registry record · Phase 2
Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 52
- Enrollment target
NCT00389441 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 52 participants.
The verdict
NCT00389441, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 52 participants
- Enrollment target
Study Summary
The primary purpose is to determine how effective AG-013736 is in shrinking thyroid cancer that is resistant to radioactive iodine
Interventions
- DRUG AG-013736
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2006-12 |
| Est. Completion | 2012-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00389441
The ClinicalTrials.gov registry entry for NCT00389441 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AG-013736 is the first listed.
NCT00389441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00389441 about?
NCT00389441 is a clinical study titled "Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer". The primary purpose is to determine how effective AG-013736 is in shrinking thyroid cancer that is resistant to radioactive iodine
What is the current status of trial NCT00389441?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 52 participants. The study started on 2006-12. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00389441?
The interventions under investigation include: AG-013736 (DRUG).
Who is sponsoring clinical trial NCT00389441?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.